A Phase II Open Label Multicenter Study of PSMA ADC in Subjects with Castration-resistant Metastatic Prostate Cancer
What is the purpose of this trial?
The objective of PSMA ADC 2301 in subjects with progressive, CRMPC is to assess the anti-tumor activity and tolerability of PSMA ADC.
- 18 Years and older
- PSMA Development Company LLC
- Last Updated:
- Study HIC#: